Related Experiment Video
Updated: Jan 22, 2026

Quantifying Agonist Activity at G Protein-coupled Receptors
Published on: December 26, 2011
Effects of melanocortin receptor agonists and antagonists on exploratory activity: a review
Robert Lalonde1, Catherine Strazielle2
1Université de Lorraine, Laboratoire Stress, Immunité, Pathogènes (UR SIMPA), Campus Santé, Bât A/B, 9, avenue de la Forêt de Haye, Vandœuvre-les-Nancy 54500, France.
Abstract:
In view of recent interest in the regenerative powers of alpha-melanocyte-stimulating hormone (α-MSH), the effects of melanocortin receptor agonists and antagonists were reviewed in open-field, elevated plus-maze, hole-board, and light-box tests of exploratory activity. In the open-field, low doses of melanocortin receptor agonists increase ambulatory activity and rearing but decrease center zone activity and duration under some conditions. In the elevated plus-maze, MSH receptor agonists generally decrease open arm exploration while MSH receptor antagonists increase open arm exploration, possibly caused by effects in amygdala, medial preoptic area, and ventromedial hypothalamus. Hole-board and light-box test results are preliminary but indicate a similar pattern of an anxiogenic response to melanocortin receptor agonists and an anxiolytic response to antagonists. At low doses, melanocortin receptor agonists are liable to increase general activity, a factor that needs to be taken into account when examining its regenerating action. Melanocortin receptor antagonists decrease anxiety in the elevated plus-maze and thereby may serve a useful function while increasing appetite.
More Related Videos
07:41A Kinetic Fluorescence-based Ca2+ Mobilization Assay to Identify G Protein-coupled Receptor Agonists, Antagonists, and Allosteric Modulators
Published on: February 20, 2018
12:02High-throughput Analysis of Mammalian Olfactory Receptors: Measurement of Receptor Activation via Luciferase Activity
Published on: June 2, 2014
Related Concept Videos
Glucagon-like Receptor Agonists
GLP-1, when administered in high doses intravenously, triggers insulin secretion, inhibits glucagon release, slows gastric emptying, reduces food intake, and restores normal insulin secretion. However, its rapid inactivation by...
Drug-Receptor Interaction: Agonist
Agonists can bind to receptors in different ways. Some agonists bind directly to the receptor's active site, mimicking the endogenous...
Drug-Receptor Interaction: Antagonist
Antagonists can be classified as competitive or noncompetitive based on their...
Antiasthma Drugs: Muscarinic Receptor Antagonists
Antimuscarinic agents compete with ACh for the same binding site on the muscarinic receptors. By binding to these receptors, they inhibit the downstream effects of ACh and block the parasympathetic...
Drugs Affecting GI Tract Motility: Serotonin Receptor Agonists
Adrenergic Antagonists: ɑ and β-Receptor Blockers